Nu-Med Plus (NUMD) Short-Term Debt issuances (2017 - 2018)

Nu-Med Plus' (NUMD) quarterly Short-Term Debt issuances came in at -$2420.0 in Q4 2018, down 21.61% year-on-year from -$3087.1 in Q4 2017, and down 4.99% quarter-over-quarter from -$2305.0 in Q3 2018.

Nu-Med Plus (NUMD) Short-Term Debt issuances (2017 - 2018) Analysis & Trends

Nu-Med Plus has disclosed Short-Term Debt issuances across 2 years of filings, most recently posting -$2420.0 for Q4 2018.

  • Short-Term Debt issuances for Q4 2018 came in at -$2420.0, down 21.61% year-over-year; the trailing twelve-month figure through Dec 2018 was -$9007.0 (up 43.71% YoY), and the FY2019 annual result was -$10959.0, down 21.67% from the prior year.
  • Short-Term Debt issuances came in at -$2420.0 for Q4 2018 at Nu-Med Plus, down from -$2305.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of -$1894.0 in Q3 2017 to a low of -$12118.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 31.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -1.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 12.88 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 37.80 Mn
10 Nu-Med Plus - - - -

Historic Data

Download Data
DateValue
Dec 31, 2018 -2,420.00
Dec 31, 2018 -2,420.00
Sep 30, 2018 -2,305.00
Sep 30, 2018 -2,305.00
Jun 30, 2018 -2,194.00
Jun 30, 2018 -2,194.00
Mar 31, 2018 -2,088.00
Mar 31, 2018 -2,088.00
Dec 31, 2017 -1,990.00
Dec 31, 2017 -1,990.00
Sep 30, 2017 -1,894.00
Sep 30, 2017 -1,894.00
Jun 30, 2017 -12,118.00
Jun 30, 2017 -12,118.00